BioMarin Pharmaceutical(DE:BM8)
€50.88-1.28 (-2.45%)
DE:BM8
BioMarin Pharmaceutical earnings date
€50.88
At close:-1.28 (-2.45%)
BioMarin Pharmaceutical (BM8) Q4 2023 Earnings Report
1 Followers
DE:BM8 Q4 2023 EPS Results
- Actual EPS
- EUR 0.10
- Consensus EPS
- EUR 0.18
- Beat/Miss
- Missed by -EUR 0.08
- One Year Ago EPS
- EUR 0.00
DE:BM8 Q4 2023 Revenue Results
- Actual Revenue
- EUR 583.85M
- Expected Revenue
- EUR 577.45M
- Beat/Miss
- Beat by +EUR 6.40M
- YoY Revenue Growth
- +25.23%
Earnings Announcement Details
- Quarter
- Q4 2023
- Date
- 02/22/2024
- Time
- After Close
- Conference Call
- Thursday, February 22, 2024
DE:BM8 Upcoming Earnings
BioMarin Pharmaceutical's next earnings date is estimated for February 24, 2027, based on past reporting schedules.
Q4 2023 Earnings Call Audio
DE:BM8 Q4 2023 Earnings Call
0:00 / 0:00
Q4 2023 Earnings Slide Deck
Q4 2023 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:BM8 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 24, 2027 | 2026 (Q4) | 0.74- | -0.22 | ― | ― |
| Nov 02, 2026 | 2026 (Q3) | -0.040.21 | -0.14 | 243.75% (+0.35) | |
| Aug 06, 2026 | 2026 (Q2) | 0.861.08 | 1.11 | -2.44% (-0.03) | |
| May 04, 2026 | 2026 (Q1) | 0.630.69 | 0.86 | -20.00% (-0.17) | |
| Feb 23, 2026 | 2025 (Q4) | 0.15-0.22 | 0.58 | -137.50% (-0.80) | |
| Oct 27, 2025 | 2025 (Q3) | -0.25-0.14 | 0.5 | -129.09% (-0.64) | |
| Aug 04, 2025 | 2025 (Q2) | 0.781.11 | 0.5 | 123.64% (+0.61) | |
| May 01, 2025 | 2025 (Q1) | 0.650.86 | 0.42 | 106.52% (+0.44) | |
| Feb 19, 2025 | 2024 (Q4) | 0.480.58 | 0.1 | 481.82% (+0.48) | |
| Oct 29, 2024 | 2024 (Q3) | 0.480.50 | 0.19 | 161.90% (+0.31) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed


